Princeton Global Asset Management »

Sab Biotherapeutics shares owned by Princeton Global Asset Management

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Princeton Global Asset Management from 13F filings

Historical chart of Princeton Global Asset Management investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Princeton Global Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Princeton Global Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.4k 500 2.70
2024-06-30 $1.6k 500 3.10
2024-03-31 $2.3k 500 4.54